Back to Search Start Over

Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19

Authors :
Lyndon Morley
Justin Liu
Adam Badzynski
Tran Truong
Zhihui Amy Liu
Mike Lovas
Monika K. Krzyzanowska
Melvin L.K. Chua
Luke Brzozowski
Alejandro Berlin
Onil Bhattacharyya
A. Keith Stewart
Carl Virtanen
Mary Beth Carpenter
Joseph A Cafazzo
Marnie Escaf
Lesley Moody
Sheena Melwani
Avi Goldfarb
Source :
JAMA Oncology
Publication Year :
2021

Abstract

Key Points Question Can virtual care (VC) be rapidly implemented across a tertiary center during the coronavirus disease 2019 (COVID-19) pandemic, and what are service capacity and quality outcomes? Findings This cohort study of 22 085 VC visits at a single cancer center suggests feasibility of an agile service design process for implementation of VC at scale. This approach preserved outpatient caseloads and maintained care quality in all 6 care-quality domains of care quality laid out by the Institute of Medicine while rendering high patient and practitioner satisfaction. Meaning These data support the value proposition of VC to safeguard system capacity, while minimizing the disruption to patient care during a pandemic.<br />Importance The coronavirus disease 2019 (COVID-19) pandemic has burdened health care resources and disrupted care of patients with cancer. Virtual care (VC) represents a potential solution. However, few quantitative data support its rapid implementation and positive associations with service capacity and quality. Objective To examine the outcomes of a cancer center–wide virtual care program in response to the COVID-19 pandemic. Design, Setting, and Participants This cohort study applied a hospitalwide agile service design to map gaps and develop a customized digital solution to enable at-scale VC across a publicly funded comprehensive cancer center. Data were collected from a high-volume cancer center in Ontario, Canada, from March 23 to May 22, 2020. Main Outcomes and Measures Outcome measures were care delivery volumes, quality of care, patient and practitioner experiences, and cost savings to patients. Results The VC solution was developed and launched 12 days after the declaration of the COVID-19 pandemic. A total of 22 085 VC visits (mean, 514 visits per day) were conducted, comprising 68.4% (range, 18.8%-100%) of daily visits compared with 0.8% before launch (P<br />This cohort study of a publicly funded comprehensive cancer center examines the outcomes of a cancer center–wide virtual care program in response to the COVID-19 pandemic.

Details

ISSN :
23742445
Volume :
7
Issue :
4
Database :
OpenAIRE
Journal :
JAMA oncology
Accession number :
edsair.doi.dedup.....52697474583c9396580840272a4b225e